Jack Allen
Stock Analyst at Robert W. Baird
Total Price Targets
11
Stocks Covered
7
Sectors
Healthcare
Most Recent
Jan 27, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Jack Allen
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| NTLA | Intellia Therapeutics, Inc. | $7.00 | $13.20 | -47.0% | 4 | Jan 27, 2026 |
| TSHA | Taysha Gene Therapies, Inc. | $12.00 | $6.38 | +88.1% | 1 | Oct 2, 2025 |
| ACLX | Arcellx, Inc. | $106.00 | $115.07 | -7.9% | 1 | Nov 6, 2024 |
| BMRN | BioMarin Pharmaceutical Inc. | $65.00 | $54.20 | +19.9% | 2 | Oct 30, 2024 |
| VYGR | Voyager Therapeutics, Inc. | $18.00 | $3.75 | +379.4% | 1 | Sep 25, 2024 |
| CRSP | CRISPR Therapeutics AG | $52.00 | $51.72 | +0.6% | 1 | May 9, 2024 |
| ALLO | Allogene Therapeutics, Inc. | $11.00 | $2.15 | +412.8% | 1 | Jun 13, 2022 |
Recent Activity
- Jan 27, 2026— Set$7.00price target onNTLA(Intellia Therapeutics, Inc.)
- Oct 30, 2025— Set$9.00price target onNTLA(Intellia Therapeutics, Inc.)
- Oct 2, 2025— Set$12.00price target onTSHA(Taysha Gene Therapies, Inc.)
- Nov 6, 2024— Set$106.00price target onACLX(Arcellx, Inc.)
- Oct 30, 2024— Set$65.00price target onBMRN(BioMarin Pharmaceutical Inc.)
- Oct 24, 2024— Set$18.00price target onNTLA(Intellia Therapeutics, Inc.)
- Sep 25, 2024— Set$18.00price target onVYGR(Voyager Therapeutics, Inc.)
- Jun 24, 2024— Set$24.00price target onNTLA(Intellia Therapeutics, Inc.)
- May 17, 2024— Set$72.00price target onBMRN(BioMarin Pharmaceutical Inc.)
- May 9, 2024— Set$52.00price target onCRSP(CRISPR Therapeutics AG)
- Jun 13, 2022— Set$11.00price target onALLO(Allogene Therapeutics, Inc.)
Frequently Asked Questions
Who is Jack Allen?
Jack Allen is a stock analyst at Robert W. Baird covering 7 stocks primarily in Healthcare. They have issued 11 price targets since Jun 13, 2022.
What stocks does Jack Allen cover?
Jack Allen currently covers 7 stocks, including NTLA, BMRN, TSHA, ACLX, VYGR.
What is Jack Allen's latest price target?
Jack Allen's most recent price target was $7.00 on NTLA (Intellia Therapeutics, Inc.), set on Jan 27, 2026.
What is Jack Allen's highest price target?
Jack Allen's highest issued price target is $106.00 on ACLX, set on Nov 6, 2024.
More Analysts at Robert W. Baird
Coverage based on publicly published price targets. Not investment advice.